Siripuram Vijay K, Wright Daniel F B, Barclay Murray L, Duffull Stephen B
Otago Pharmacometrics Group, School of Pharmacy, University of Otago, Dunedin, New Zealand.
Departments of Gastroenterology & Clinical Pharmacology, Christchurch Hospital, Christchurch, New Zealand.
J Pharmacokinet Pharmacodyn. 2017 Oct;44(5):415-423. doi: 10.1007/s10928-017-9530-4. Epub 2017 Jun 13.
Identifiability is an important component of pharmacokinetic-pharmacodynamic (PKPD) model development. Structural identifiability is concerned with the uniqueness of the model parameters for a set of perfect input-output data and deterministic identifiability with the precision of parameter estimation given imperfect input-output data. We introduce two subcategories of deterministic identifiability, external and internal, and consider factors that distinguish between these forms. We define external deterministic identifiability as a function of externally controllable variables, i.e., the design, and internal deterministic identifiability as a function of the model and its parameter values. The concepts are explored using three common PK and PKPD models, and verified for their precision for the selected set of parameter values under optimal design.
可识别性是药代动力学-药效学(PKPD)模型开发的一个重要组成部分。结构可识别性涉及一组完美输入-输出数据的模型参数的唯一性,而确定性可识别性则涉及给定不完美输入-输出数据时参数估计的精度。我们引入了确定性可识别性的两个子类别,即外部和内部,并考虑区分这些形式的因素。我们将外部确定性可识别性定义为外部可控变量(即设计)的函数,将内部确定性可识别性定义为模型及其参数值的函数。使用三种常见的药代动力学和PKPD模型探讨了这些概念,并在最优设计下针对选定的参数值集验证了它们的精度。